[Basic Science of Cancer Cachexia].

Area of Science:

• Metabolic disease
• Pathogenesis
• Inflammation

Background:

• Cachexia is a complex metabolic disease characterized by systemic inflammation.
• The precise molecular mechanisms driving cachexia remain incompletely understood.
• Current knowledge relies heavily on mouse models, with potential for clinical translation.

Purpose of the Study:

• To review current knowledge on the pathogenesis of cancer cachexia.
• To emphasize findings from mouse models with potential future clinical applications.
• To highlight the disruption of metabolic homeostasis and organ cross-talk.

Main Methods:

• Review of existing literature on cancer cachexia pathogenesis.
• Analysis of findings from animal models, primarily mouse models.
• Focus on molecular mechanisms and organ-specific metabolic changes.

Main Results:

• Pro-inflammatory cytokines and TGF-b superfamily members disrupt organ cross-talk, causing metabolic collapse.
• Key features include skeletal muscle atrophy (via enhanced proteolysis, reduced synthesis) and adipose tissue atrophy (via lipolysis).
• Liver steatosis and increased gluconeogenesis, alongside CNS inflammation causing anorexia and increased energy expenditure, are observed.

Conclusions:

• Elucidating cancer cachexia pathogenesis is crucial for developing novel preventive and therapeutic strategies.
• Increased awareness and research are needed to advance the field.
• Targeting inflammatory mediators shows promise for future cancer cachexia treatments.